March 2012 FDA is an Exceptional Agency FDA was substantially - - PowerPoint PPT Presentation

march 2012 fda is an exceptional agency
SMART_READER_LITE
LIVE PREVIEW

March 2012 FDA is an Exceptional Agency FDA was substantially - - PowerPoint PPT Presentation

March 2012 FDA is an Exceptional Agency FDA was substantially underfunded for two decades. We thank Congress for recent increases. FDAs responsibilities (and the world it regulates) continues to grow rapidly in size and complexity.


slide-1
SLIDE 1

March 2012

slide-2
SLIDE 2

FDA is an Exceptional Agency

  • FDA was substantially underfunded for two
  • decades. We thank Congress for recent increases.
  • FDA’s responsibilities (and the world it regulates)

continues to grow rapidly in size and complexity.

  • FDA will be required to carry out new activities in FY 13

that are not paid for in the FY12 base funding. that are not paid for in the FY12 base funding.

  • FDA needs to transform itself into a 21st Century

regulatory agency.

  • FDA should be a true priority for our nation, deserving

exceptional status when appropriations decisions are made.

1

slide-3
SLIDE 3

FDA Regulates . . . 25% of Consumer Spending

Pet food and animal feed Food additives Cosmetics Infant formulas Dietary supplements

2

Microwaves and x-ray equipment Medical devices Vaccines, blood products, biologics 80% of nation’s food supply Drugs

slide-4
SLIDE 4

New mandates and responsibilities are not in FY 12 base funding

New Congressional Mandates

  • Biosimilars
  • Food Safety and

Modernization Act Additional Growth in Responsibilities

  • Globalization
  • Conversion to risk-

based inspections Modernization Act (FSMA)

  • National Security

(MCM)

  • Potential new

requirements in user fee reauthorization based inspections

  • Scientific complexity
  • Promoting Innovation
  • Public Health

Emergencies

3

slide-5
SLIDE 5

GLOBALIZATION

4

slide-6
SLIDE 6

Globalization Challenges

  • Food
  • 10-15% of all food consumed by U.S. households is imported
  • Nearly 50% of fresh fruits and 20% of vegetables are imported
  • 80% of seafood eaten domestically come from outside the U.S.
  • Food imports have increased an average of 10% per year from 2005-2011
  • Devices

5

  • Devices
  • Medical device imports have grown at over 10% per year from 2005-2011
  • Half of all medical devices used in the U.S. are imported
  • Drugs
  • 80% of pharmaceutical ingredients used in the U.S. are manufactured

abroad

  • 40% of finished drug products are manufactured abroad
  • Pharmaceutical product imports increased nearly 13%/year from 2005-2011
slide-7
SLIDE 7

More than 300,000 Foreign Facilities ..… in 200 Countries

2177 2417 2500 3000

Inspections of Foreign Establishments* have Increased To meet this significant challenge, FDA is:

  • Further increasing

inspections

  • Focusing on high-risk

949 1245 1424 2177 500 1000 1500 2000 2008 2009 2010 2011 2012

6

  • Focusing on high-risk

facilities

  • Entering into more

agreements with foreign regulators

_____

* Includes food, drug and device

establishments

slide-8
SLIDE 8

FOOD AND MEDICAL PRODUCTS

7

slide-9
SLIDE 9

Transforming the Way FDA Regulates Food

  • Target high-risk food facilities for more frequent inspection
  • Train state/local inspectors on Federal requirements
  • Use a new, risk-based system (PREDICT) to identify

imported foods that require additional scrutiny

Risk-based inspections

  • Implementation of preventive controls for known food

safety hazards

Change from Re-active

safety hazards

  • Establish monitoring systems to ensure effectiveness
  • Establish performance targets for food facilities

Re-active to Pro-active System

  • Perform a greater number of foreign food facility

inspections

  • Increase inspections at ports of entry
  • Expand agreements with states and with foreign agencies

Accelerate number of inspections

8

slide-10
SLIDE 10

Transforming the Way FDA Regulates Medical Products

  • Improve and modernize FDA processes to promote

biomedical innovation and product development

  • Accelerate FDA guidance development and regulatory

reforms to improve predictability/transparency

Development

  • f regulations

and guidance

  • Enhance in vitro and pre-clinical safety methodologies

Expansion of Pre-

  • Enhance in vitro and pre-clinical safety methodologies
  • Develop and validate modern clinical trial

methodologies and drug development tools

  • Continued development and enhancement of

surveillance systems to track adverse events

Pre- and Post- Market Safety

  • Regulatory science activities & pharmacogenomics
  • Facilitate drug and device development meetings
  • Implement biosimilars legislation & PDUFA V add-ons
  • Strengthen global activities and supply chain integrity

Sustain and Increase Core Programs

9

slide-11
SLIDE 11

Conclusion

  • FDA has broad mandate for a relatively small

agency

  • FDA is a core function of government
  • FDA’s mission and responsibilities are

increasing

  • .

increasing

  • FDA needs funding to transform into a 21st

Century regulatory agency

  • FDA should be a priority…and deserves

exceptional status when appropriations decisions are made

10

slide-12
SLIDE 12

A strong FDA benefits all Americans: A strong FDA benefits all Americans:

Patients, consumers, health professionals, industry....and the whole world benefits, too.

For more information, contact: Ladd Wiley, Executive Director, lwiley@StrengthenFDA.org , 202-887-4083 Steven Grossman, Deputy Executive Director, sgrossman@strengthenfda.org, 301-539-9660